Lysosome AKT Targeting in Metastatic Cancer

Ziv Radisavljevic1

  • 1Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115.

Insights

Metastatic cancer arises from overactive lysosomes, driven by the fungus Aspergillus fumigatus activating the AKT gene network. Targeting this network with antifungal medication and redox balance modification eliminates cancer metastasis.

Area of Science:

  • Oncology
  • Mycology
  • Molecular Biology

Background:

  • Metastatic cancer is a complex disease characterized by the spread of cancer cells to distant sites.
  • Hyperactivated lysosomes have been implicated in the progression of metastatic cancer.
  • The AKT gene network plays a crucial role in cellular processes, including lysosome regulation.

Purpose of the Study:

  • To investigate the role of hyperactivated lysosomes and the Aspergillus fumigatus-mediated AKT gene network in cancer metastasis.
  • To explore a novel therapeutic strategy targeting this network to suppress the metastatic phenotype.

Main Methods:

  • Analysis of the molecular mechanisms linking lysosome activation, Aspergillus fumigatus, and the AKT gene network.
  • Intervention strategies involving modulation of redox balance and administration of antifungal medication.
  • Clinical observation of the therapeutic effects on metastasis suppression.

Main Results:

  • Hyperactivated lysosomes, induced by Aspergillus fumigatus, lead to permanent activation of the AKT gene network.
  • Targeting this network through redox balance alteration and antifungal treatment effectively eliminated the metastatic phenotype.
  • The study demonstrated the suppression of metastasis of unknown origin through this principal gene-targeting mechanism.

Conclusions:

  • The interplay between hyperactivated lysosomes, Aspergillus fumigatus, and the AKT gene network is a key driver of cancer metastasis.
  • Modulating redox balance and utilizing antifungal agents offers a promising therapeutic approach to combat metastatic cancer.
  • This novel gene-targeting strategy has shown clinical efficacy in suppressing metastasis.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Lysosomes01:31

Lysosomes

Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
25.0K